Inventiv Health — Q1 2016 Earnings Presentation
15 slides from Inventiv Health's earnings presentation, May 13, 2016
Slide 1: inVentiv Health First Quarter 2016 Earnings Presentation
inVentiv Health First Quarter 2016 Earnings Presentation May 16, 2016 Exhibit 99.1
Slide 2: Forward-looking statements
This presentation contains forward-looking statements. These forward-looking statements reflect our current views about future events and are subject to risks, uncertainties and assumptions. We caution readers that certain important factors may have affected and could in the future affect our actual
Slide 3: Quarterly Highlights
Quarterly Highlights Record financial performance in Q1 built on recent momentum Organic net revenue(1) growth of 23% (20% reported net revenue growth) Adjusted EBITDA(2) growth of 62% to $85mm Actively identified and continued to execute on margin improvement opportunities Macro environment remaine
Slide 4: Clinical Update
Clinical Update Performance accelerated in Q1 Organic net revenue(1) growth of 19% (16% reported net revenue growth) Adjusted EBITDA(2) growth of 65% Backlog conversion accelerated on full service projects Growth was strongest in core, complex therapeutic areas Business development remained strong N
Slide 5: Commercial Update
Commercial Update Continued momentum in Q1 Organic net revenue(1) growth of 27% (24% reported net revenue growth) Adjusted EBITDA(2) growth of 44% Selling Solutions and Communications business strength drove results Double digit growth in both service offerings Significant demand and pipeline for ou
Slide 6: Consolidated inVentiv Health Q1 2016 Financial Update
Consolidated inVentiv Health Q1 2016 Financial Update The sum of the segments do not reconcile to Consolidated inVentiv Health due to the elimination of intersegment revenue which totaled approximately $4.5 million for the three months ended 3/31/2016 and approximately $3.2 million for the three mon
Slide 7: Clinical Performance
Clinical Performance Net Revenues(1) ($ millions) Adjusted EBITDA(2) ($ millions) 16% 65% 12.1% 17.2% The sum of the segments do not reconcile to Consolidated inVentiv Health due to the elimination of intersegment revenue which totaled approximately $4.5 million for the three months ended 3/31/2016
Slide 8: Clinical Backlog
Clinical Backlog Net Book-to-Bill = Net New Wins / Revenue Earned. (1)
Slide 9: Commercial Performance
Commercial Performance The sum of the segments do not reconcile to Consolidated inVentiv Health due to the elimination of intersegment revenue which totaled approximately $4.5 million for the three months ended 3/31/2016 and approximately $3.2 million for the three months ended 3/31/2015. The sum of
Slide 10: Adjusted Free Cash Flow and Net Leverage
Adjusted Free Cash Flow and Net Leverage Adjusted Free Cash Flow(1) ($ millions) Net Leverage(2) ($ millions) Adjusted Free Cash Flow = Adjusted EBITDA – Capex +/- Changes in Net Working Capital (changes in Net Working Capital was approximately $(15)M in Q1 2015 and approximately $(42)M in Q1 2016).
Slide 11: Appendix
Appendix fe inVentiv > 11 ©2016 AllRights Reserved Health
Slide 12: EBITDA Reconciliation, Quarter Ended March 31, 2016 & 2015
For the Quarter Ended March 31, 2016 & March 31, 2015 ($ millions) Adjusted EBITDA Reconciliation Note: Please refer to slide 15 for footnotes. QTD Q1 2016 QTD Q1 2015 Net Income (loss) from continuing operations ($18.6) ($45.0) 8.2 4.5 Interest expense, net 55.9 56.5 Equity Investment Income (0.0)
Slide 13: EBITDA Reconciliation, Quarter Ended March 31, 2016
For the Quarter Ended March 31, 2016 ($ millions) Adjusted EBITDA Reconciliation Note: Please refer to slide 15 for footnotes.
Slide 14: EBITDA Reconciliation, Quarter Ended March 31, 2015
For the Quarter Ended March 31, 2015 ($ millions) Adjusted EBITDA Reconciliation Note: Please refer to slide 15 for footnotes.
Slide 15: Adjusted EBITDA Footnotes
Adjusted EBITDA Footnotes (a) Represents non-cash compensation charges. prior acquisitions. THL to our Consolidated Financial Statements. sustained profitability. our core on-going operations. (g) Represents employee termination costs. relocation pr franchise t advisors. a iventiv > 15 ©2016 AllRigh